{
  "paper_metadata": {
    "pmid": "25884701",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information and penetrance data from a study on ovarian cancer in French Canadian women."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8765delAG",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 34,
        "demographics": "439 women with ovarian cancer, primarily French Canadian",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 34,
        "affected_count": 34,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The mutation is associated with a significant increase in risk for ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong evidence for pathogenicity based on recurrence in the population.",
      "source_location": "Table 2, Row 4",
      "additional_notes": "Identified in women with serous subtype tumours.",
      "key_quotes": [
        "Mutations were identified in women with serous, endometrioid, mixed cell, and undifferentiated adenocarcinomas."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3398del5",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 34,
        "demographics": "439 women with ovarian cancer, primarily French Canadian",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 34,
        "affected_count": 34,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The mutation is associated with a significant increase in risk for ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong evidence for pathogenicity based on recurrence in the population.",
      "source_location": "Table 2, Row 5",
      "additional_notes": "Identified in women with serous subtype tumours.",
      "key_quotes": [
        "Mutations were identified in women with serous, endometrioid, mixed cell, and undifferentiated adenocarcinomas."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6085T",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 34,
        "demographics": "439 women with ovarian cancer, primarily French Canadian",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 34,
        "affected_count": 34,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The mutation is associated with a significant increase in risk for ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong evidence for pathogenicity based on recurrence in the population.",
      "source_location": "Table 2, Row 6",
      "additional_notes": "Identified in women with serous subtype tumours.",
      "key_quotes": [
        "Mutations were identified in women with serous, endometrioid, mixed cell, and undifferentiated adenocarcinomas."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3002K",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 34,
        "demographics": "439 women with ovarian cancer, primarily French Canadian",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 34,
        "affected_count": 34,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The mutation is associated with a significant increase in risk for ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong evidence for pathogenicity based on recurrence in the population.",
      "source_location": "Table 2, Row 7",
      "additional_notes": "Identified in women with serous subtype tumours.",
      "key_quotes": [
        "Mutations were identified in women with serous, endometrioid, mixed cell, and undifferentiated adenocarcinomas."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Frequency of the most common BRCA1 and BRCA2 mutations among French Canadian women with ovarian cancer",
      "variants_extracted": 4
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 4,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}